Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use

about

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.

P2860

Q48157504-7A015F45-473B-4FBA-83ED-960D05A1B2C6

P2860

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use

Item

http://www.wikidata.org/entity/Q38967866

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Performance comparison of next ...... termining HIV-1 coreceptor use

@en

type

Item

label

Performance comparison of next ...... termining HIV-1 coreceptor use

@en

prefLabel

Performance comparison of next ...... termining HIV-1 coreceptor use

@en

P1476

Performance comparison of next ...... termining HIV-1 coreceptor use

@en

P2093

Caroline Lefebvre

http://www.w3.org/2001/XMLSchema#string

Florence Nicot

http://www.w3.org/2001/XMLSchema#string

Jacques Izopet

http://www.w3.org/2001/XMLSchema#string

Michelle Cazabat

http://www.w3.org/2001/XMLSchema#string

Nicolas Jeanne

http://www.w3.org/2001/XMLSchema#string

Olivier Delfour

http://www.w3.org/2001/XMLSchema#string

Romain Carcenac

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism

Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1.

A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.

Maraviroc for previously treated patients with R5 HIV-1 infection

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.

Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.

Genotypic prediction of HIV-1 subtype D tropism

P2888

srep42215

P304

42215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP42215

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Delobel

Stéphanie Raymond

Karine Sauné

P577

2017-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083739385

http://www.w3.org/2001/XMLSchema#string

P698

28186189

http://www.w3.org/2001/XMLSchema#string

P932

5301480

http://www.w3.org/2001/XMLSchema#string

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use

about

P2860

P2860

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P932